Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal-Onset Seizures”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT06377930
What this trial is testing

Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Who this might be right for
Focal Onset Seizures
Rapport Therapeutics Inc. 30
Not applicableUnknownNCT04737837
What this trial is testing

A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset Epilepsy

Who this might be right for
EpilepsyFocal-Onset Seizure
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT01179854
What this trial is testing

Remegal Different Doses in Patients With Refractory Partial Seizures

Who this might be right for
Drug SafetyNormal Drug ToleranceSelf Efficacy
Valexfarm 60
Early research (Phase 1)Active Not RecruitingNCT06899230
What this trial is testing

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007

Who this might be right for
Drug Resistant EpilepsyFocal Seizure
iQure Australia Pty Ltd 72
Large-scale testing (Phase 3)Study completedNCT00113815
What this trial is testing

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Who this might be right for
Partial Seizure DisorderEpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 118
Large-scale testing (Phase 3)Study completedNCT00310375
What this trial is testing

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Who this might be right for
Epilepsy
GlaxoSmithKline 181
Not applicableStudy completedNCT01178437
What this trial is testing

Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy

Who this might be right for
Epilepsy
cerbomed GmbH 7
Testing effectiveness (Phase 2)Ended earlyNCT04686786
What this trial is testing

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 105
Large-scale testing (Phase 3)Ended earlyNCT00067431
What this trial is testing

The Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

Who this might be right for
Partial Seizure Disorder
Abbott 300
Post-approval studies (Phase 4)Active Not RecruitingNCT06453213
What this trial is testing

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Who this might be right for
Focal Onset Seizure
SK Life Science, Inc. 49
Large-scale testing (Phase 3)Study completedNCT00143130
What this trial is testing

Pregabalin In Partial Seizures Extension Study

Who this might be right for
Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 227
Large-scale testing (Phase 3)WithdrawnNCT03108729
What this trial is testing

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Who this might be right for
Epilepsy
Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT06309966
What this trial is testing

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Not applicableStudy completedNCT03082222
What this trial is testing

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Who this might be right for
Focal Epilepsy
Eisai GmbH 246
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Not applicableLooking for participantsNCT06241924
What this trial is testing

Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

Who this might be right for
Parkinson DiseaseEpilepsy
University Hospital, Bordeaux 30
Testing effectiveness (Phase 2)Ended earlyNCT03370120
What this trial is testing

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Who this might be right for
Drug-Resistant EpilepsyFocal-Onset Seizures
UCB Biopharma SRL 406
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Testing effectiveness (Phase 2)Ended earlyNCT05493293
What this trial is testing

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Who this might be right for
Focal Onset SeizureFocal Onset Epilepsy
Neurocrine Biosciences 82
Next Page